Role of clinical history in beta-lactam hypersensitivity
Open Access
- 28 May 2021
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Allergy and Clinical Immunology
- Vol. 21 (4) , 320-326
Abstract
Purpose of Review: Understand how the clinical history has been used to risk stratify patients reporting a beta-lactam allergy, both in clinical care pathways and predictive models. Recent findings: Drug allergy clinical care pathways have emerged as a safe and effective method of stratifying patients with a reported beta-lactam allergy into risk categories, with ‘low-risk’ patients able to proceed straight to direct challenges or test doses. These methods have streamlined antibiotic stewardship policies and penicillin allergy de-labeling. However, how to define ‘low-risk’ has been subject to much debate. New research has developed predictive models that utilize the clinical history to assess a patient's true risk of beta-lactam allergy. Summary: The clinical history has long been an essential part of drug allergy evaluation and has proven invaluable within the past decade in the development of drug allergy clinical pathways. Evidence-based predictive models that use the clinical history to assess a patient's true risk of beta-lactam allergy offer tremendous promise, but differ in crucial areas such as the populations they study, the predictor variables they use, and the ultimate accuracy they attain. These models highlight key aspects of the drug allergy history and pave the way for future large-scale research.Keywords
This publication has 43 references indexed in Scilit:
- Assessing the Diagnostic Properties of a Graded Oral Provocation Challenge for the Diagnosis of Immediate and Nonimmediate Reactions to Amoxicillin in ChildrenJAMA Pediatrics, 2016
- Therapeutic Guidelines: Antibiotic. Version 15.Australian Prescriber, 2015
- Comparative Effectiveness of Beta-Lactams Versus Vancomycin for Treatment of Methicillin-SusceptibleStaphylococcus aureusBloodstream Infections Among 122 HospitalsClinical Infectious Diseases, 2015
- Management of allergy to penicillins and other beta‐lactamsClinical & Experimental Allergy, 2015
- Penicillin and Beta-Lactam Allergy: Epidemiology and DiagnosisCurrent Allergy and Asthma Reports, 2014
- InternationalConsensus on drug allergyAllergy, 2014
- Drug Allergy: An Updated Practice ParameterAnnals of Allergy, Asthma & Immunology, 2010
- Skin testing and oral penicillin challenge in patients with a history of remote penicillin allergyAnnals of Allergy, Asthma & Immunology, 2008
- The status of US allergy/immunology physicians in the 21st century: A report from the American Academy of Allergy, Asthma & Immunology Workforce CommitteeJournal of Allergy and Clinical Immunology, 2007
- Clinical evaluation of Pharmacia CAP System™ RAST FEIA amoxicilloyl and benzylpenicilloyl in patients with penicillin allergyAllergy, 2001